Abigene, a Prospective, Multicentric Study of Abiraterone Acetate Pharmacogenetics in Metastatic Castration-Resistant Prostate Cancer

• 主要な著者: Jean-Marc Ferrero (著者), Hakim Mahammedi (著者), Gwenaelle Gravis (著者), Guilhem Roubaud (著者), Philippe Beuzeboc (著者), Remi Largillier (著者), Delphine Borchiellini (著者), Claude Linassier (著者), Nathalie Ebran (著者), Tanguy Pace-Loscos (著者), Marie-Christine E (著者), Renaud Schiappa (著者), Jocelyn Gal (著者), Gérard Milano (著者)
• フォーマット: 図書
• 出版事項: MDPI AG, 2023-02-01T00:00:00Z.
• 主題: article
• オンライン･アクセス: Connect to this object online.

Abiraterone acetate (AA) is the first-in-class of drugs belonging to the second-generation of agents inhibiting androgen neosynthesis in advanced prostate cancer. A cumulative experience attests that germinal gene polymorphisms may play a role in the prediction of anticancer agent pharmacodynamics v...